Keratoconus Surgery: Treatment Options and Costs
What Keratoconus Does to Your Cornea
Keratoconus causes your cornea (the clear front layer of your eye) to thin and bulge into a cone-like shape. This distortion bends light unevenly as it enters your eye, creating blurry and distorted vision that glasses may not fully correct. The condition usually begins in the teenage years or early twenties and progresses over time.
Your eye doctor detects keratoconus through corneal topography, a mapping test that measures the shape of your cornea. Early stages may look like regular astigmatism. As the cone steepens, your vision distortion increases and standard glasses become less effective.
In early keratoconus, glasses or standard soft contacts may correct your vision. As the condition progresses, soft lenses cannot conform to the irregular corneal shape. Your eye doctor may move you to rigid gas-permeable (RGP) lenses or scleral lenses that vault over the cornea to create a smooth optical surface.
Scleral lenses rest on the white part of your eye (the sclera) and create a tear-filled space over your cornea. Many patients with moderate to severe keratoconus achieve their best vision with scleral lenses. These are often used as long-term optical management alongside or instead of surgery.
Your eye doctor may recommend surgery when contact lenses can no longer provide adequate vision, when the cornea is too steep for lens fitting, or when the disease is progressing rapidly. The type of surgery depends on your disease stage and the specific goal, whether to halt progression, improve shape, or replace the cornea.
Surgical decisions are based on your corneal thickness, the severity of the cone, your best corrected vision with contacts, and whether the disease is still progressing. Your eye doctor discusses all options and helps you decide the best path.
Corneal Cross-Linking (CXL)
Corneal collagen cross-linking (CXL) is the standard first-line surgical intervention for progressive keratoconus. Your eye doctor applies riboflavin (vitamin B2) drops to your cornea, then exposes it to UV-A light at 365 nanometers. This combination strengthens the collagen bonds in the corneal tissue, stiffening the cornea to halt further bulging.
CXL does not reverse existing keratoconus. It stops the progression. After cross-linking, your cornea maintains its current shape rather than continuing to thin and steepen. Some patients experience modest improvement in corneal shape over the following year.
The FDA-approved standard approach (epithelium-off) removes the thin outer layer of the cornea before applying riboflavin and UV light. This allows deeper penetration of the treatment. The epithelium-on approach leaves the outer layer intact, making recovery faster but potentially less effective.
Most insurance plans cover the standard epithelium-off procedure when progressive keratoconus is documented. The epithelium-on approach often remains an out-of-pocket expense because it lacks the same level of FDA approval.
CXL costs about $2,500 to $4,000 per eye out-of-pocket (NVISION Centers). Health economic analyses show that early CXL is more cost-effective than waiting until a corneal transplant becomes necessary (AAO EyeNet). If your insurance covers the procedure, your out-of-pocket cost is your deductible and coinsurance.
Check with your insurance company before scheduling. Provide documentation from your eye doctor showing disease progression, which is typically required for coverage approval.
Surgical Options for Advanced Keratoconus
Intacs are small plastic ring segments that your eye doctor inserts into the cornea to flatten the cone and improve its shape. This procedure can improve contact lens tolerance and delay or avoid the need for a corneal transplant. Typical cost is about $1,500 to $2,500 per eye.
Intacs do not cure keratoconus. They reshape the cornea enough to improve vision and make contact lens fitting easier. Your eye doctor may combine Intacs with cross-linking to both stabilize and reshape the cornea.
For advanced keratoconus that is not manageable with CXL or specialty contacts, corneal transplant surgery replaces part or all of your damaged cornea with donor tissue. Two main types are used:
- Deep anterior lamellar keratoplasty (DALK) replaces the front layers of the cornea while preserving your own endothelium (inner layer). This lowers rejection risk.
- Penetrating keratoplasty (PKP) replaces the full thickness of the cornea. This is currently the most common surgery for advanced keratoconus.
Corneal transplant costs range from about $13,000 (outpatient) to $28,000 (inpatient) without insurance (GoodRx, 2024). Most health insurance plans cover corneal transplantation for keratoconus as a medically necessary procedure.
The Athens Protocol combines CXL with topography-guided laser treatment (PRK) in one session. CXL stabilizes the cornea while the laser treatment improves the corneal shape and visual acuity. Multiple clinical series show increasing success with this combined approach (AAO EyeNet, 2023).
This combination is suitable for selected candidates whose corneas are thick enough for safe laser treatment. Your eye doctor evaluates your corneal thickness and disease stage to determine whether you qualify. Not every keratoconus patient is a candidate for the combined approach.
Recovery and What to Expect
Recovery from standard CXL takes about one to two weeks for the epithelium to heal. You may experience discomfort, light sensitivity, and blurry vision during the first few days. Your eye doctor prescribes drops and provides a protective contact lens to wear during healing.
Visual improvement after CXL is gradual. Your cornea continues to stabilize over the following 6 to 12 months. Your doctor monitors your corneal shape with follow-up topography scans during this period.
Recovery from corneal transplant takes longer. You use prescription eye drops for months to prevent rejection. Full visual recovery can take 12 to 18 months. Sutures may stay in your cornea for a year or longer before your doctor removes them.
Even after a successful transplant, you may still need glasses or specialty contact lenses for best vision. The donor cornea creates a new surface, but the prescription it produces varies from patient to patient.
After any keratoconus procedure, your eye doctor monitors your corneal shape and eye health at regular intervals. Cross-linking patients are checked for stability. Transplant patients are monitored for rejection signs, which can occur months or years after surgery. Report any sudden vision changes, redness, or pain to your doctor immediately.
Many patients use specialty contact lenses after surgery for their best possible vision. Your eye doctor refits your lenses once your cornea has stabilized from the procedure.
Keratoconus Treatment Questions
Most health insurance plans cover corneal cross-linking (epithelium-off) and corneal transplantation as medically necessary procedures when keratoconus is documented. Your eye doctor provides the clinical documentation your insurer needs. Check your specific plan for deductible and coinsurance requirements.
CXL stops progression but does not reverse existing corneal damage. Some patients see modest improvement in corneal shape over the months following the procedure. Most patients continue wearing glasses or contacts after CXL for clear vision.
Your eye doctor recommends a transplant when contact lenses no longer provide usable vision and your cornea is too damaged for cross-linking or ring segments alone. This decision is based on corneal measurements, your best corrected vision, and your quality of life with current options.
Standard LASIK is contraindicated for keratoconus because it removes corneal tissue from an already-thin cornea, which can worsen the condition. Topography-guided PRK may be combined with CXL (Athens Protocol) in selected cases, but only under close specialist supervision.
Corneal transplants in keratoconus patients have high success rates. Many last 15 to 20 years or longer. Rejection is possible at any time, so lifelong follow-up with your eye doctor is necessary. If rejection occurs early, medication can often reverse it.
CXL stabilizes the cornea, and recurrence after successful cross-linking is uncommon. In a transplanted cornea, keratoconus does not recur in the donor tissue. However, the transplant can develop other issues over time that require monitoring or additional treatment.
Discuss Your Options With Your Eye Doctor
Your eye doctor can evaluate your keratoconus stage and recommend the treatment that fits your situation. Early intervention with cross-linking can prevent the need for more invasive surgery later.